Ellenbogen Michael sold $501K of EVLV
Ellenbogen Michael sold 80,745 shares of Evolv Technologies Holdings, Inc. (EVLV) at $6.21 ($0.50M total) on 2026-06-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a concrete insider selling event (80,745 shares at $6.21) but does not reveal new business performance or forward-looking guidance.
Market read
Useful for monitoring insider activity and potential sentiment, but not a standalone fundamental catalyst.
What to watch
Traders may over-weight insider sales; without accompanying guidance, trial, or contract updates, the signal is typically secondary to broader catalysts.
Background
The article is an SEC Form 4 insider transaction for Evolv Technologies Holdings, Inc., reported by a director.
Ticker impact
Evolv Technologies director Michael Ellenbogen sold 80,745 shares in an open-market transaction under a pre-arranged 10b5-1 plan.
Likely limited near-term impact; any effect is more sentiment/positioning than fundamentals.
The filing is a primary Form 4 disclosure, but it does not include new operating/financial information—only a planned insider sale.
Market effects
No sector-level read-through; this is company-specific ownership-change disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale was executed under a pre-arranged 10b5-1 plan, it may reflect liquidity/portfolio management rather than bearish expectations.
Key entities
- issuerEvolv Technologies Holdings, Inc.
Subject of the Form 4 insider transaction; director Michael Ellenbogen sold shares under a 10b5-1 plan.
- insiderMichael Ellenbogen
Director who executed the open-market sale disclosed on Form 4.
